Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tue Jan 27, 3:12AM CST

Deutsche Bank analyst Falko Friedrichs maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €44.00.

Claim 50% Off TipRanks Premium

Friedrichs covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Fresenius SE & Co. KGaA, and Siemens Healthineers AG. According to TipRanks, Friedrichs has an average return of -2.4% and a 41.37% success rate on recommended stocks.

In addition to Deutsche Bank , Fresenius Medical Care AG & Co. KGaA also received a Hold from Kepler Capital ‘s Oliver Reinberg in a report issued on January 21. However, on January 23, J.P. Morgan maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

0H9X market cap is currently €10.81B and has a P/E ratio of 15.18.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.